C

CVRx Inc
NASDAQ:CVRX

Watchlist Manager
CVRx Inc
NASDAQ:CVRX
Watchlist
Price: 14.85 USD 0.54% Market Closed
Market Cap: 360.3m USD
Have any thoughts about
CVRx Inc?
Write Note

Intrinsic Value

CVRX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CVRX stock under the Base Case scenario is 11 USD. Compared to the current market price of 14.85 USD, CVRx Inc is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CVRX Intrinsic Value
11 USD
Overvaluation 26%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
CVRx Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CVRX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CVRX?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
CVRx Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about CVRx Inc

Provide an overview of the primary business activities
of CVRx Inc.

What unique competitive advantages
does CVRx Inc hold over its rivals?

What risks and challenges
does CVRx Inc face in the near future?

Has there been any significant insider trading activity
in CVRx Inc recently?

Summarize the latest earnings call
of CVRx Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CVRx Inc.

Provide P/S
for CVRx Inc.

Provide P/E
for CVRx Inc.

Provide P/OCF
for CVRx Inc.

Provide P/FCFE
for CVRx Inc.

Provide P/B
for CVRx Inc.

Provide EV/S
for CVRx Inc.

Provide EV/GP
for CVRx Inc.

Provide EV/EBITDA
for CVRx Inc.

Provide EV/EBIT
for CVRx Inc.

Provide EV/OCF
for CVRx Inc.

Provide EV/FCFF
for CVRx Inc.

Provide EV/IC
for CVRx Inc.

Show me price targets
for CVRx Inc made by professional analysts.

What are the Revenue projections
for CVRx Inc?

How accurate were the past Revenue estimates
for CVRx Inc?

What are the Net Income projections
for CVRx Inc?

How accurate were the past Net Income estimates
for CVRx Inc?

What are the EPS projections
for CVRx Inc?

How accurate were the past EPS estimates
for CVRx Inc?

What are the EBIT projections
for CVRx Inc?

How accurate were the past EBIT estimates
for CVRx Inc?

Compare the revenue forecasts
for CVRx Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CVRx Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CVRx Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of CVRx Inc compared to its peers.

Compare the P/E ratios
of CVRx Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing CVRx Inc with its peers.

Analyze the financial leverage
of CVRx Inc compared to its main competitors.

Show all profitability ratios
for CVRx Inc.

Provide ROE
for CVRx Inc.

Provide ROA
for CVRx Inc.

Provide ROIC
for CVRx Inc.

Provide ROCE
for CVRx Inc.

Provide Gross Margin
for CVRx Inc.

Provide Operating Margin
for CVRx Inc.

Provide Net Margin
for CVRx Inc.

Provide FCF Margin
for CVRx Inc.

Show all solvency ratios
for CVRx Inc.

Provide D/E Ratio
for CVRx Inc.

Provide D/A Ratio
for CVRx Inc.

Provide Interest Coverage Ratio
for CVRx Inc.

Provide Altman Z-Score Ratio
for CVRx Inc.

Provide Quick Ratio
for CVRx Inc.

Provide Current Ratio
for CVRx Inc.

Provide Cash Ratio
for CVRx Inc.

What is the historical Revenue growth
over the last 5 years for CVRx Inc?

What is the historical Net Income growth
over the last 5 years for CVRx Inc?

What is the current Free Cash Flow
of CVRx Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for CVRx Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CVRx Inc

Current Assets 123.9m
Cash & Short-Term Investments 100.2m
Receivables 9m
Other Current Assets 14.7m
Non-Current Assets 3.8m
PP&E 3.8m
Other Non-Current Assets 26k
Current Liabilities 10.9m
Accounts Payable 3.3m
Accrued Liabilities 7.7m
Non-Current Liabilities 51.5m
Long-Term Debt 49.2m
Other Non-Current Liabilities 2.3m
Efficiency

Earnings Waterfall
CVRx Inc

Revenue
47.3m USD
Cost of Revenue
-7.5m USD
Gross Profit
39.8m USD
Operating Expenses
-98.6m USD
Operating Income
-58.9m USD
Other Expenses
400k USD
Net Income
-58.5m USD

Free Cash Flow Analysis
CVRx Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CVRX Profitability Score
Profitability Due Diligence

CVRx Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
27/100
Profitability
Score

CVRx Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

CVRX Solvency Score
Solvency Due Diligence

CVRx Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
43/100
Solvency
Score

CVRx Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CVRX Price Targets Summary
CVRx Inc

Wall Street analysts forecast CVRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVRX is 16.83 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

Lowest
Price Target
13.13 USD
12% Downside
Average
Price Target
16.83 USD
13% Upside
Highest
Price Target
21 USD
41% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CVRX?

Click here to dive deeper.

Dividends

CVRx Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CVRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CVRX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

CVRx Inc

Country

United States of America

Industry

Health Care

Market Cap

359.4m USD

Dividend Yield

0%

Description

CVRx, Inc. develops proprietary active implantable technology to treat high blood pressure and heart failure. The company is headquartered in Minneapolis, Minnesota and currently employs 109 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its platform technology offers BAROSTIM, designed to control the brain to address the imbalance of the autonomic nervous system (ANS), which causes heart failure (HF) and other cardiovascular diseases. The Company’s product, BAROSTIM NEO, is a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction (HFrEF). BAROSTIM NEO provides baroreflex activation therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. BAROSTIM NEO consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead.

Contact

MINNESOTA
Minneapolis
9201 West Broadway Avenue, Suite 650
+17634162850.0
www.cvrx.com

IPO

2021-06-30

Employees

109

Officers

President, CEO & Director
Mr. Kevin Hykes
Chief Financial Officer
Mr. Jared Oasheim
Chief Marketing & Strategy Officer
Mr. Paul Verrastro
Vice President of Operations
Mr. Paul Pignato
VP & General Counsel
Ms. Jonelle R. Burnham
Chief Human Resources Officer
Ms. Tonya A. Austin SPHR
Show More
Senior Vice President of Global Clinical Affairs
Ms. Jennifer E. Englund
Chief Medical Officer
Dr. Philip B. Adamson M.D., M.Sc.
Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics
Ms. Bonnie Handke M.B.A., R.N.
Chief Revenue Officer
Mr. Robert Allen John
Show Less

See Also

Discover More
What is the Intrinsic Value of one CVRX stock?

The intrinsic value of one CVRX stock under the Base Case scenario is 11 USD.

Is CVRX stock undervalued or overvalued?

Compared to the current market price of 14.85 USD, CVRx Inc is Overvalued by 26%.

Back to Top